Sep 20, 2021 / 08:30PM GMT
Operator
Hello, good afternoon. My name is Grace Delaka. And I will be your conference operator today. At this time, I would like to welcome everyone to the Merck ESMO Investor Call. (Operator Instructions) I would now like to turn the call over to Mr. Peter Dannenbaum, Vice President of Investor Relations. Please go ahead, sir.
Peter Dannenbaum - Merck & Co., Inc. - VP of IR
Thank you, Grace, and good afternoon, everyone. Welcome to Merck's 2021 ESMO investor call. Dr. Dean Li, President of Merck Research Labs, will lead off our presentation with some high-level thoughts about Merck's oncology program. He will be followed by Dr. Roy Baynes, Head of Global Clinical Development, who will provide highlights of the more significant data sets that Merck presented at ESMO. Jannie Oosthuizen, Head of Human -- Oncology Human Health will provide a commercial perspective, and then we'll have time for your questions.
Before we get started, we'd like to remind you that some of the statements that we make during today's call may be considered forward-looking statements
Merck & Co Inc Oncology Event at ESMO 2021 Transcript
Sep 21, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers